Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer
Clinical trial NCT06349967 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06349967
- Sponsor
- West China Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2027-04-30
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.